The carbamate -(N,N-dimethylcarbamoyloxy)-2-pyridylmerhylene)-4- (4-ph
enyl)diazinecarboxamide amide chloride (MHP 133) is the parent for a n
ew class of pyridinium salts which inhibit acetylcholinesterase (AChE)
in vitro as well as in vivo. Fourteen new derivatives of MHP 133 have
been synthesized with the intention of improving their hydrophobicity
while maintaining their propensity to inhibit acetylcholinesterase. U
pon prolonged incubation with AChE, the pyridinium salts exhibit progr
essive time-dependent inhibition according to first order kinetics wit
h k(obs)/[1] values ranging from 3 to 345 M(-1) s(-1). The enzyme did
not regain any activity after prolonged incubation with the inhibitors
(1 day). The partition coefficients for each inhibitor were evaluated
in octanol/water in order to determine their hydrophobic character as
hydrophobicity is a key prerequisite for crossing the blood brain bar
rier.